Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
J Hepatol ; 75(2): 275-283, 2021 08.
Article in English | MEDLINE | ID: mdl-33746085

ABSTRACT

BACKGROUND & AIMS: To what extent patients with alcohol-related decompensated cirrhosis can improve until recovery from decompensation remains unclear. We aimed to investigate the probability of recovery and delisting due to improvement in patients with alcohol-related decompensated cirrhosis on the waiting list (WL) for liver transplantation (LT). METHODS: We conducted a registry-based, multicenter, retrospective study including all patients admitted to the LT WL in Catalonia (Spain) with the indication of alcohol-, HCV-, cholestasis- or non-alcoholic steatohepatitis-related decompensated cirrhosis between January 2007 and December 2018. Competing-risk analysis was used to investigate variables associated with delisting due to improvement in patients with alcohol-related decompensated cirrhosis. Criteria for delisting after improvement were not predefined. Outcomes of patients after delisting were also studied. RESULTS: One-thousand and one patients were included, 420 (37%) with alcohol-related decompensated cirrhosis. Thirty-six (8.6%) patients with alcohol-related decompensated cirrhosis were delisted after improvement at a median time of 29 months after WL admission. Lower model for end-stage liver disease (MELD) score, higher platelets and either female sex or lower height were independently associated with delisting due to improvement, while time of abstinence did not reach statistical significance in multivariate analysis (p = 0.055). Five years after delisting, the cumulative probability of remaining free from liver-related death or LT was 76%, similar to patients with HCV-related decompensated cirrhosis delisted after improvement. CONCLUSIONS: A significant proportion of LT candidates with alcohol-related cirrhosis can be delisted due to improvement, which is predicted by low MELD score and higher platelet count at WL admission. Women also have a higher probability of being delisted after improvement, partially due to reduced early access to LT for height discrepancies. Early identification of patients with potential for improvement may avoid unnecessary transplants. LAY SUMMARY: Patients with alcohol-related cirrhosis can improve until being delisted in approximately 9% of cases. Low model for end-stage liver disease score and high platelet levels at admission predict delisting after improvement, and women have higher probabilities of being delisted due to improvement. Long-term outcomes after delisting are generally favorable.


Subject(s)
Liver Cirrhosis, Alcoholic/therapy , Liver Transplantation/classification , Waiting Lists , Adult , Antiviral Agents/therapeutic use , Female , Humans , Liver Transplantation/methods , Liver Transplantation/statistics & numerical data , Male , Middle Aged , Spain
2.
Dig Dis Sci ; 66(1): 231-237, 2021 01.
Article in English | MEDLINE | ID: mdl-32124198

ABSTRACT

INTRODUCTION: Biliary strictures are a common complication of donation after circulatory death (DCD) liver transplantation (LT) and require multiple endoscopic retrograde cholangiopancreatography (ERCP) procedures. Three classification systems, based on cholangiograms, have been proposed for categorizing post-LT biliary strictures. We examined the interobserver agreement for each of the three classifications. METHODS: DCD LT recipients from 2012 through March 2017 undergoing ERCP for biliary strictures were included in the study. Initial cholangiograms delineating the entire biliary tree prior to endoscopic intervention were selected. One representative cholangiogram was selected from each ERCP. Five interventional endoscopists independently viewed each anonymized cholangiogram and classified the post-LT stricture according to each of the three classification systems. The Ling classification proposes four types of post-LT strictures based on their location. The Lee classification proposes four classes based on location and number of intrahepatic strictures. The binary system classifies strictures into anastomotic or non-anastomotic types. The Krippendorff's alpha reliability estimate was used to grade the strength of agreement as "poor," "fair," "moderate," "good," or "excellent" for values between 0-0.20, 0.21-0.4, 0.41-0.6, 0.61-0.08, and 0.81-1, respectively. RESULTS: One hundred DCD LT recipients (age 57.07 ± 8.8 years; 71 males) were initially evaluated. Of these, 49 patients who underwent 206 ERCP procedures for biliary strictures were included in the analysis. One hundred thirty-nine cholangiograms were selected and subsequently classified by five endoscopists. Interobserver agreement for post-LT biliary strictures was 0.354 for Ling classification (fair agreement), 0.405 for Lee classification (fair agreement), and 0.421 for the binary classification (moderate agreement). The binary classification provided the least amount of detail regarding the location and number of biliary strictures. DISCUSSION: The currently available classification systems for assessing post-LT biliary strictures have sub-optimal interobserver agreement. A better-designed classification system is needed for categorizing post-LT biliary strictures.


Subject(s)
Biliary Tract/diagnostic imaging , Liver Transplantation/classification , Shock/classification , Shock/diagnostic imaging , Tissue and Organ Procurement/classification , Aged , Cholangiography/classification , Cholangiography/trends , Female , Humans , Liver Transplantation/trends , Male , Middle Aged , Observer Variation , Retrospective Studies , Tissue and Organ Procurement/trends
3.
Transplant Proc ; 47(9): 2768-70, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26680090

ABSTRACT

Reuse of liver graft for transplantation is extremely uncommon. We report the 1st case of reuse of liver graft from a recipient who had hepatitis B virus (HBV) infection, 11 years after the 1st transplantation. Our relay liver transplantation challenged conventional thinking because of late reuse of graft in the presence of HBV infection. Moreover, both the 1st and the 2nd donors were of advanced age. The key questions were whether the liver graft could be reused safely, especially in the setting of HBV infection, and technical concerns during organ procurement and implantation. The absence of HBV replication was confirmed with negative hepatitis B surface antigen and undetectable serum HBV DNA in the 2nd donor. Based on our experience in managing HBV infection after liver transplantation, we were confident that the adequately suppressed HBV infection in the donor would not jeopardize graft function and that the graft would be able to withstand another ischemia-perfusion injury to continue to function well in our recipient.


Subject(s)
Hepatitis B/immunology , Liver Transplantation/methods , Transplants/virology , Aged , Brain Death , DNA, Viral/blood , Fatal Outcome , Hepatitis B/drug therapy , Hepatitis B Surface Antigens/blood , Hepatitis B Surface Antigens/immunology , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Humans , Liver Transplantation/classification , Male , Middle Aged , Reoperation , Tissue and Organ Harvesting , Tissue and Organ Procurement , Transplants/surgery , Transplants/transplantation
4.
Clin. transl. oncol. (Print) ; 17(12): 988-995, dic. 2015. tab, ilus
Article in English | IBECS | ID: ibc-147437

ABSTRACT

Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related death worldwide. Surveillance with abdominal ultrasound every 6 months should be offered to patients with a high risk of developing HCC: Child-Pugh A-B cirrhotic patients, all cirrhotic patients on the waiting list for liver transplantation, high-risk HBV chronic hepatitis patients (higher viral load, viral genotype or Asian or African ancestry) and patients with chronic hepatitis C and bridging fibrosis. Accurate diagnosis, staging and functional hepatic reserve are crucial for the optimal therapeutic approach. Characteristic findings on dynamic CT/MR of arterial hyperenhancement with "washout" in the portal venous or delayed phase are highly specific and sensitive for a diagnosis of HCC in patients with previous cirrhosis, but a confirmed histopathologic diagnosis should be done in patients without previous evidence of chronic hepatic disease. BCLC classification is the most common staging system used in Western countries. Surgical procedures, local therapies and systemic treatments should be discussed and planned for each patient by a multidisciplinary team according to the stage, performance status, liver function and comorbidities. Surgical interventions remain as the only curative procedures but both local and systemic approaches may increase survival and should be offered to patients without contraindications (AU)


No disponible


Subject(s)
Humans , Male , Female , /standards , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Ultrasonography/methods , Liver Transplantation/classification , Liver Transplantation/methods , Hepatitis, Chronic/metabolism , Hepatitis, Chronic/pathology , Pharmaceutical Preparations/administration & dosage , Tomography, X-Ray Computed/methods , Carcinoma, Hepatocellular/surgery , Carcinoma, Hepatocellular/therapy , Ultrasonography/standards , Liver Transplantation/nursing , Liver Transplantation/rehabilitation , Hepatitis, Chronic/complications , Hepatitis, Chronic/diagnosis , Pharmaceutical Preparations/supply & distribution , Tomography, X-Ray Computed/instrumentation
5.
Liver Int ; 35(6): 1739-47, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25349066

ABSTRACT

BACKGROUND & AIMS: We studied new-onset diabetes after transplantation (NODAT) in liver transplantation with grafts donated after brain death (DBD) or circulatory death (DCD), focusing on the early post-transplant period. METHODS: A total of 430 non-diabetic primary liver transplant recipients [DCD, n = 90 (21%)] were followed up for 30 months (range 5-69). NODAT was defined as the composite endpoint of one of following: (i) Two non-fasting plasma glucose levels > 11.1 mmol/L ≥ 30 days apart, (ii) oral hypoglycaemic drugs ≥ 30 days consecutively (iii) insulin therapy ≥ 30 days and (iv) HbA1c ≥ 48 mmol/L. Resolution of NODAT was defined as cessation of treatment or hyperglycaemia. RESULTS: Total of 81/430 (19%) patients developed NODAT. Incidence and resolution of NODAT over time showed significantly different patterns between DCD and DBD liver graft recipients; early occurrence, high peak incidence and early resolution were seen in DCD. In multivariate logistic regression including age, ethnicity, HCV, tacrolimus level and pulsed steroids, only DCD was independently associated with NODAT at day 15 post-transplant (OR 6.5, 95% CI 2.3-18.4, P < 0.001), whereas age and pulsed steroids were significant factors between 30-90 days. Combined in multivariate Cox regression model for NODAT-free survival, graft type, age and pulsed steroids were each independent predictor for decreased NODAT-free survival in the first 90-postoperative days. CONCLUSION: Early peak of NODAT in DCD graft recipients is a novel finding, occurring independently from known risk factors. Donor warm ischaemia and impact on insulin sensitivity should be further studied and could perhaps be associated with graft function.


Subject(s)
Diabetes Mellitus/epidemiology , Liver Transplantation/adverse effects , Warm Ischemia/adverse effects , Adolescent , Adult , Aged , Blood Glucose/chemistry , Diabetes Mellitus/diagnosis , Female , Glycated Hemoglobin/chemistry , Humans , Hyperglycemia/complications , Hypoglycemic Agents/therapeutic use , Immunosuppressive Agents/therapeutic use , Insulin Resistance , Liver Transplantation/classification , Logistic Models , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Risk Factors , Transplant Recipients , Young Adult
9.
Rev. gastroenterol. Perú ; 30(4): 350-356, oct.-dic. 2010. ilus
Article in Spanish | LILACS, LIPECS | ID: lil-576333

ABSTRACT

El artículo revisa la experiencia única en el Perú de 10 años de trasplantes realizada por el departamento de trasplantes del Hospital Nacional Guillermo Almenara Irigoyen (HNGAI), describiendo la historia, resultados quirúrgicos en adultos y niños, retrasplantes, trasplantes combinados hígado-riñon, las diferentes complicaciones encontradas y toda la experiencia recogida en los 72 trasplantes realizados hasta la presentación de este artículo.


The article reviews the experience in 10 years of hepatic transplants performed by The Transplant Department of the National Hospital Guillermo Almenara Irigoyen (HNGAI), describing the history, surgical outcomes in adults and children, retransplantation, combined liver-kidney transplants, complications in 72 transplants performed at the time of submission of the article.


Subject(s)
Humans , Male , Female , Postoperative Complications , Liver Transplantation/classification , Liver Transplantation/methods , Kidney Transplantation , Peru
10.
Rev. GASTROHNUP ; 12(2, Supl.1): S14-S19, mayo-ago. 2010.
Article in English | LILACS | ID: lil-645158

ABSTRACT

La hepatitis autoinmune (HAI), es una enfermedad inflamatoria crónica y progresiva, que se caracteriza histológicamente por un denso infiltrado de células mononucleares en vías portales, y cuya patogenia se le atribuye a una reacción inmune frente a autoantígenos hepatocelulares demostrado serológicamente por la presencia de autoanticuerpos específicos y aumento en los niveles de las aminotransferasas y de inmunoglobulina tipo IgG, en ausencia de una etiología conocida. Son reconocidos dos tipos de HAI en la infancia: HAI tipo I, que se caracteriza por la presencia de anticuerpos (anti músculo liso SMA) y/o antinucleares (ANA), y la HAI tipo II,que se caracteriza por anticuerpos antimicrosomales de riñón hígado (anti-LKM). La etiología de la HAI es desconocida, aunque tanto factores genéticos como ambientales están implicados en su expresión. El fenotipo clínico de la HAI en niños varía en gran medida, va desde una evolución leve a un curso fulminante. La HAI es sensible a la terapia inmunosupresora. El trasplante hepático está indicado en pacientes que presentan insuficiencia hepática fulminante (encefalopatía) y los que desarrollan enfermedad hepática terminal.


Autoimmune hepatitis (HAI) is a chronic and progressive inflammatory disease, characterizedhistologically by a dense infiltrate of mononuclear cells in the process portals, and whose pathogenesis is attributed to an immune response against hepatocellular autoantigens demonstratedserologically by the presence of specific autoant ibodies and increased levels of aminotransferases and immunoglobulin IgG, in the absence of known etiology. Recognized two types of HAI in childhood: type I, characterized by the presence of antibodies (smooth muscle anti SMA) and / or antinuclear (ANA) and type II, characterized by anti-microsomal antibodies liver kidney (anti-LKM). The etiology of HAI is unknown, a l though both gene t i c and environmental factors are involved in its expression. The clinical phenotype of the HAI in children varies greatly, ranging from a slight evolution to a fulminant course. The HAI is sensitive to immunosuppressive therapy. Liver transplantation is indicated in patients with fulminant hepatic failure (encephalopathy) andthose who develop end-stage liver disease.


Subject(s)
Humans , Male , Female , Child , Hepatitis, Autoimmune/etiology , Hepatitis, Autoimmune/mortality , Hepatitis, Autoimmune/pathology , Hepatitis, Autoimmune/prevention & control , Hepatitis, Autoimmune/virology , Liver Transplantation/classification , Liver Transplantation/mortality , Liver Transplantation/pathology , Epidemiology/classification , Epidemiology/history
11.
Rev. GASTROHNUP ; 12(2, Supl.1): S31-S37, mayo-ago. 2010. ilus
Article in Spanish | LILACS | ID: lil-645161

ABSTRACT

La inmunosupresión en niños con trasplante hepático, ha evolucionado con dos momentos clave: la disponibilidad de los inhibidores de calcineurina ciclosporina y tacrolimus. La inmunosupresión primaria se diseña sobre la base de un inhibidor de calcineurina como fármaco principal. Los esteroides se incluyen en la pauta de inmunosupresión primaria en la mayoría de los centros. Las pautas habituales a largo plazo consisten en ciclosporina o tacrolimus, en monoterapia a niveles inferiores a los deseados en el periodo precoz postrasplante, o en combinación con dosis bajas de esteroide. Los inhibidor e s de c a l c ineur ina induc en vasoconstricción arterial aguda y crónica que causa nefrotoxicidad, con disminución del filtrado glomerular y tubulopatía. Los niveles ensangre de ciclosporina o de tacrolimus se determinan para evaluar el estado de inmunosupresión. La edad de adolescente y adulto joven es una etapa de riesgo para el injerto por ser frecuente la omisión accidental de dosis de medicación inmunosupresora, una irregularidad que es difícil de evaluar en su extensión a pesar de una buena relación médicopaciente y frecuentes chequeos. El rechazo tiene una incidencia entre el 30 y 50% de los pacientes, entre los días 5 y 30 postrasplante.


Immunosuppression in children with liver transplantation has evolved with two key moments: the availability of calcineurin inhibitors, cyclosporine and tacrolimus. The primary immunosuppression is designed on the basis of a calcineurin inhibitor as primary drug. Steroids are included in the pr imary immunosuppression regimen in most schools. The long-term normal patterns consist of cyclosporine or tacrolimus as monotherapy to lower than desired levels in the early period aftertransplantation, or in combination with low dose steroid. Calcineurin inhibitors induce arterial vasoconstriction causing acute and chronic nephrotoxicity, with reduced glomerular filtration and tubular. Blood levels of cyclosporine or tacrolimus are determined to assess the state of immunosuppression. The age of adolescence and young adulthood is a time of risk to the graft by the accidental omission to be frequent doses ofimmunosuppressive medication, an irregularitywhich is difficult to assess its extent in spite of a good doctor-patient relationship and frequentcheckups. The rejection has an incidence between 30 and 50% of patients, between 5 and 30 aftertransplantation.


Subject(s)
Humans , Male , Female , Child , Calcineurin/administration & dosage , Calcineurin/analysis , Calcineurin , Calcineurin/pharmacology , Calcineurin , Calcineurin/therapeutic use , Immunosuppression Therapy/methods , Immunosuppression Therapy , Liver Transplantation/classification , Liver Transplantation , Cyclosporine/administration & dosage , Cyclosporine/pharmacology , Cyclosporine/toxicity , Cyclosporine , Cyclosporine/therapeutic use , Tacrolimus/administration & dosage , Tacrolimus , Tacrolimus/pharmacology , Tacrolimus/toxicity , Tacrolimus/therapeutic use
12.
Liver Transpl ; 15(8): 924-30, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19642122

ABSTRACT

Biliary reconstruction using Roux-en-Y choledochojejunostomy has been suggested as a risk factor for the development of nonanastomotic biliary strictures (NAS) after liver transplantation. Roux-en-Y reconstruction, however, is preferentially used in patients transplanted for primary sclerosing cholangitis (PSC), and the disease itself is also associated with a higher incidence of NAS. The aim of this study was to determine whether Roux-en-Y reconstruction is really an independent risk factor for NAS. A series of 486 consecutive adult liver transplants were studied. Biliary reconstruction in patients transplanted for PSC was either by Roux-en-Y choledochojejunostomy or by duct-to-duct anastomosis, depending on the quality of the recipient's extrahepatic bile duct. Univariate and multivariate statistical analyses were used to identify risk factors for the development of NAS. The overall incidence of NAS was 16.5% (80/486). In univariate analyses, the following variables were significantly associated with NAS: PSC as the indication for transplantation, type of biliary reconstruction (Roux-en-Y versus duct-to-duct), and postoperative cytomegalovirus infection. After multivariate logistic regression analysis, PSC as the indication for transplantation (odds ratio, 2.813; 95% confidence interval, 1.624-4.875; P < 0.001) and postoperative cytomegalovirus infection (odds ratio, 2.098; 95% confidence interval, 1.266-3.477; P = 0.004) remained as independent risk factors for NAS. Biliary reconstruction using Roux-en-Y choledochojejunostomy was not identified as an independent risk factor for NAS. In conclusion, the association between Roux-en-Y choledochojejunostomy and NAS observed in previous studies can be explained by the more frequent use of Roux-en-Y reconstruction in patients with PSC. Roux-en-Y reconstruction itself is not an independent risk factor for NAS. Liver Transpl 15:924-930, 2009. (c) 2009 AASLD.


Subject(s)
Anastomosis, Roux-en-Y/adverse effects , Choledochostomy/adverse effects , Liver Transplantation/adverse effects , Liver Transplantation/classification , Liver Transplantation/methods , Adult , Cholangitis, Sclerosing/surgery , Cholangitis, Sclerosing/therapy , Cytomegalovirus Infections/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Postoperative Complications , Regression Analysis , Risk Factors
13.
Am J Transplant ; 9(3): 586-91, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19191773

ABSTRACT

Although living donor liver transplantation (LDLT) has been shown to decrease waiting-list mortality, little is known of its financial impact relative to deceased donor liver transplantation (DDLT). We performed a retrospective cohort study of the comprehensive resource utilization, using financial charges as a surrogate measure-from the pretransplant through the posttransplant periods-of 489 adult liver transplants (LDLT n = 86; DDLT n = 403) between January 1, 2000, through December 31, 2006, at a single center with substantial experience in LDLT. Baseline characteristics differed between LDLT versus DDLT with regards to age at transplantation (p = 0.02), male gender (p < 0.01), percentage Caucasians (p < 0.01) and transplant model for end-stage liver disease (MELD) score (p < 0.01). In univariate analysis, there was a trend toward decreased total transplant charges with LDLT (p = 0.06), despite increased surgical charges associated with LDLT (p < 0.01). After adjustment for the covariates that were associated with financial charges, there was no significant difference in total transplant charges (p = 0.82). MELD score at transplant was the strongest driver of resource utilization. We conclude that at an experienced transplant center, LDLT imposes a similar overall financial burden than DDLT, despite the increased complexity of living donor surgery and the addition of the costs of the living donor. We speculate that LDLT optimizes transplantation by transplanting healthier and younger recipients.


Subject(s)
Hospitals/statistics & numerical data , Liver Transplantation/statistics & numerical data , Tissue Donors/statistics & numerical data , Cadaver , Female , Humans , Inpatients , Liver Transplantation/classification , Liver Transplantation/economics , Male , Middle Aged , Treatment Outcome
14.
Transplantation ; 84(5): 572-9, 2007 Sep 15.
Article in English | MEDLINE | ID: mdl-17876268

ABSTRACT

BACKGROUND: The UK and Ireland Liver Transplant Audit collects information on all liver transplantations that are carried out in both countries. In this paper, we describe these transplantations and their outcomes in adult patients according to primary liver disease diagnosis, type of transplantation and period. METHODS: A prospective cohort study of 7906 orthotopic liver transplantations carried out between April 1994 and June 2005 in the United Kingdom and Ireland. Multivariable logistic regression was used to investigate improvements in mortality according to period of transplantation adjusted for recipient and donor characteristics. RESULTS: A total of 6,850 transplantations were done in adults (patients 16 years or older). Of these, 836 (12.2%) were first super-urgent procedures (33.7% men; median age 36 years), and 5,072 (74.0%) first elective procedures (60.0% men; median age 52 years). The percentage of patients who received a donor organ with abnormal appearance gradually increased, especially in patients receiving an elective transplant. Mortality at 90 days after first super-urgent transplant decreased from 29.6% (95% confidence interval: 23.5% to 36.9%) before October 1, 1996 to 16.0% (11.7% to 21.7%) after October 1, 2002. Considering the same time periods, mortality at 90 days after first elective transplant decreased from 10.6% (8.9% to 12.7%) to 7.7% (6.3% to 9.3%). Multivariable analysis demonstrated that these improvements cannot be explained by changes in the risk profile of recipients and donors. CONCLUSIONS: Patients undergoing a liver transplantation in the most recent years had a better survival than patients with similar characteristics transplanted 10 years earlier. Posttransplant survival has improved despite a deteriorating quality of donor organs.


Subject(s)
Liver Transplantation/statistics & numerical data , Adult , Cohort Studies , Female , Humans , Ireland/epidemiology , Liver Diseases/mortality , Liver Diseases/pathology , Liver Diseases/surgery , Liver Transplantation/classification , Liver Transplantation/mortality , Male , Middle Aged , Time Factors , Tissue Donors/statistics & numerical data , Treatment Outcome , United Kingdom/epidemiology
15.
Liver Transpl ; 12(5): 792-800, 2006 May.
Article in English | MEDLINE | ID: mdl-16628679

ABSTRACT

The primed status of T cells is markedly different among liver transplant recipients, due to a lifetime of antigen exposure and reduced thymopoiesis by aging, and diseases. This study aims to characterize the preoperative immunological status of CD8+ T cell subpopulations and relate it to the outcome for liver transplant recipients. We classified 112 liver transplant recipients into 5 groups, based on hierarchical clustering of the CD8+CD45 isoform proportion of T cells. In Groups I and II (pediatric), the naive T cell proportion was more than 50%. In adult recipients, Group III was characterized by a naive T cell proportion of 50%, Group IV had the greatest effector/memory T cells (EM), and Group V had the greatest proportion of effector T cells. In Groups IV and V, the effector T cell proportion was considerably higher, and was accompanied by marked downregulation of the CD27+CD28+ subsets and upregulation of interferon gamma (IFN)-gamma, tumor necrosis factor-alpha, and perforin expression. Group V recipients tended to be complicated postoperatively, with a significantly reduced survival rate (1 yr, 66.8%) and markedly reduced Eastern Cooperative Oncology Group performance status.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Liver Transplantation/immunology , Adolescent , Adult , Aged , Child , Child, Preschool , Cytokines/biosynthesis , Cytotoxicity, Immunologic , Humans , Infant , Infant, Newborn , Leukocyte Common Antigens/analysis , Liver Transplantation/adverse effects , Liver Transplantation/classification , Living Donors , Middle Aged , Postoperative Complications/etiology
16.
Nurs Times ; 102(3): 30-2, 2006.
Article in English | MEDLINE | ID: mdl-16440973

ABSTRACT

Advanced surgical techniques and the development of effective immunosuppressive therapies have enabled liver transplantation to be performed in any age group with a high graft and patient survival rate.


Subject(s)
Liver Transplantation , Humans , Immunosuppression Therapy/adverse effects , Immunosuppression Therapy/methods , Incidence , Liver Transplantation/adverse effects , Liver Transplantation/classification , Liver Transplantation/methods , Patient Selection , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Risk Factors
17.
Cir. Esp. (Ed. impr.) ; 78(4): 231-237, oct. 2005. ilus, tab
Article in Es | IBECS | ID: ibc-040897

ABSTRACT

Objetivo. El objetivo de este trabajo fue estudiar una serie de 1.000 trasplantes hepáticos (TH) y evaluar los cambios experimentados en el tiempo de los donantes y receptores utilizados, así como los resultados obtenidos. Material y método. Con el fin de evaluar las diferencias entre el inicio y la actualidad, se compararon los primeros 100 trasplantes (entre junio 1988 y junio de 1990) con los últimos 200 trasplantes (entre enero de 2001 y junio de 2003). Resultados. Destaca el aumento en la edad de los donantes (23 ± 10 frente a 45 ± 19), el cambio en la etiología de la muerte cerebral (traumatismo craneoencefálico: el 78 frente al 23,5%; accidente cerebrovascular: el 17 frente al 52,5%) y el mayor porcentaje de donantes procedentes de programas alternativos a la donación estándar de cadáver en el segundo período (donante vivo: 12,5%). Asimismo, el inicio de la técnica de Piggy-back y la realización de la anastomosis biliar sin tutorización. La supervivencia actuarial del paciente al año fue superior en el segundo período con respecto al primero (el 84 frente al 91,3%).El porcentaje de retrasplante total de toda la serie fue del 9,5%. La supervivencia actuarial del retrasplante fue a 1, 5 y 10 años del 67,7, 51,3 y 39,4%, respectivamente. Conclusión. La falta de donantes y el aumento de la lista de espera han hecho que aceptemos donantes de peor calidad, receptores en situaciones más críticas y que iniciemos programas alternativos e innovadores. Pese a ello, no se han alterado los buenos resultados alcanzados, debido a una mejoría del manejo del paciente antes, durante y después del trasplante (AU)


The aim of this study was to evaluate a consecutive series of 1000 liver transplants performed in our institution and to evaluate changes over time in donors and recipients, as well as results. Material and method. To clearly evaluate the differences between the initial transplantation period and the present period, the first 100 consecutive liver transplantations performed (June 1988-June 1990) and the last 200 consecutive liver transplantations performed (January 2001-June 2003) were compared. Results. Donor age increased (23±10 vs. 45±19), the etiology of brain death changed (severe head injury: 78% vs. 23.5%; stroke: 17% vs. 52.5%) and the percentage of donors from alternative methods to cadaveric donors increased (living donors: 12.5%) in the second period. Regarding recipients, the piggy-back technique and biliary anastomosis without T-tube were introduced in the second period. Actuarial 1-year survival was higher in the second period than in the first (84% vs. 91.3%). The need for retrasplantation in the entire series was 9.5%, with actuarial survival at 1, 5 and 10 years of 67.7%, 51.3% and 39.4%, respectively. Conclusion. Because of the lack of donors and the greater number of patients on the waiting list, poorer quality donors and more critical recipients have been accepted and alternative and innovative programs have been started. Nevertheless, due to improvement in patient management before, during and after transplantation, the previous good results have been maintained (AU)


Subject(s)
Male , Female , Humans , Liver Transplantation/methods , Liver Transplantation/statistics & numerical data , Postoperative Complications/diagnosis , Tissue Donors/classification , Tissue Donors/supply & distribution , Living Donors/classification , Living Donors/supply & distribution , Liver Transplantation/classification , Liver Transplantation/trends , Retrospective Studies , Transplants
18.
AMIA Annu Symp Proc ; : 1144, 2005.
Article in English | MEDLINE | ID: mdl-16779430

ABSTRACT

We investigate the problem of constructing a sequential classification procedure allowing for a classification into two (risk) groups at an average minimum cost or at the earliest possible time. The quality of the procedure is maintained by specified upper bounds for the conditional errors of the entire procedure.


Subject(s)
Classification/methods , Oligonucleotide Array Sequence Analysis , Humans , Liver Transplantation/classification
SELECTION OF CITATIONS
SEARCH DETAIL
...